0000827054-25-000133
SEC filingNet sales fell 13.4% YoY to $1.08B as customer inventory corrections drove a 580 bps gross margin decline to 53.6%.
For the three months ended June 30, 2025, Microchip Technology reported net sales of $1,075.5 million, a 13.4% decline from $1,241.3 million in the same period last year. The decrease was attributed to many customers maintaining high inventory levels and delaying or reducing orders, compounded by adverse economic conditions including slow economic activity, business uncertainty, persistent inflation, and high interest rates.
Gross profit fell to $576.7 million (53.6% of sales) from $736.9 million (59.4% of sales) in the prior year, a contraction of 580 basis points. The primary driver was an unfavorable net impact of sales volume, product mix, and geographic mix. Additionally, unabsorbed capacity charges increased by $15.6 million year-over-year as the company operated manufacturing facilities below normal levels. Inventory reserve charges provided a favorable $1.0 million impact, while higher licensing revenue (which carries no cost of sales) contributed a favorable $10.9 million.
Operating income plummeted to $32.0 million (3.0% of sales) from $219.6 million (17.7% of sales) in the prior year. Research and development expenses rose 5.7% to $255.5 million, and selling, general and administrative expenses increased 5.8% to $159.3 million, both driven by higher employee compensation and share-based compensation costs partially offset by restructuring savings. Amortization of acquired intangible assets decreased to $107.6 million from $123.0 million. Special charges and other, net totaled $22.2 million, primarily related to restructuring expenses including the closure of the Tempe, Arizona wafer fabrication facility (Fab 2) and employee separation costs, compared to $2.6 million in the prior year. The company reported a net loss of $18.6 million versus net income of $129.3 million in the prior year.
Mixed-signal microcontrollers, the largest product line at 49.5% of net sales, saw revenue decline 17.4% to $532.6 million. Analog product revenue decreased 4.4% to $316.2 million, representing 29.4% of sales. The 'Other' category (FPGA, royalties, memory, manufacturing services) fell 14.8% to $226.7 million, accounting for 21.1% of sales. All geographies experienced declines: Americas down to $307.6 million (28.6% of sales), Europe down to $225.4 million (21.0%), and Asia down to $542.5 million (50.4%). Distributor inventory improved to 29 days from 33 days at March 31, 2025.
Management noted a significant sequential improvement in business in the first quarter of fiscal 2026 compared to the fourth quarter of fiscal 2025, with net sales increasing across all product lines and geographies. The company is executing a recovery plan implemented in March 2025, reducing inventory and days of inventory. Most factory expansion activity remains paused. Capital expenditures for the next 12 months are expected to be at or below $100 million. The company believes current inventory and production capacity are adequate to fulfill projected customer requirements. Management expects gross margins to continue fluctuating based on capacity utilization, product mix, manufacturing yields, and competitive conditions.
As of June 30, 2025, Microchip held $566.5 million in cash and equivalents, down from $771.7 million at March 31, 2025, primarily due to financing outflows. Total debt net of discounts and issuance costs was $5,458.1 million, a decrease of $172.3 million from the prior quarter, reflecting repayment of all Commercial Paper ($174.1 million) and no new borrowings. Stockholders' equity declined to $6,857.1 million from $7,078.3 million, driven by net loss and dividend payments. Inventory decreased to $1,169.1 million from $1,293.5 million, with lower finished goods and work in process. Deferred revenue fell to $418.5 million from $597.9 million, of which $334.3 million relates to long-term supply agreements.
Total purchase commitments were $678.4 million as of June 30, 2025, consisting of wafer purchase obligations and manufacturing supply capacity reservations. The timing of these commitments is: $225.9 million within fiscal 2026 (ending March 2026), $243.4 million in fiscal 2027-2028, and $209.1 million thereafter. Additionally, the company has indemnification contingencies up to $197.0 million for technology license agreements, and possible tax exposures in Malaysia ($410 million) and Germany ($92 million) under dispute.
During the quarter, Microchip did not repurchase any common stock; the remaining authorization under the $4.0 billion program is approximately $1.56 billion. Common dividends of $0.455 per share totaled $245.5 million, and Series A Preferred dividends of $25.1 million were paid. No new debt was issued; the company repaid $174.1 million of Commercial Paper. Capital expenditures were $17.9 million, or 1.7% of net sales, primarily for ongoing investments. The company also used $12.4 million from stock issuance under employee plans and $8.4 million for tax withholdings on RSUs.
Financial information is reported for two segments: semiconductor products and technology licensing. For the three months ended June 30, 2025, semiconductor products generated net sales of $1,042.5 million (down 14.5% YoY) and gross profit of $543.7 million. Technology licensing contributed $33.0 million in net sales (up 48.6% YoY) and gross profit of $33.0 million, with no cost of sales. The company does not allocate operating expenses or assets to segments. Geographic mix is not disclosed in the notes.
Operating cash flow (OCF) of $275.6M was generated despite a net loss of $18.6M, reflecting strong non-cash add-backs: depreciation/amortization of $171.1M, share-based compensation of $52.9M, and a $125.0M inventory decrease. The OCF/Net Income ratio is not meaningful due to the loss. Capex intensity fell significantly to $17.9M (6.5% of OCF) from $72.9M (19.3% of OCF) a year ago, indicating reduced capacity investment. Free cash flow (OCF minus capex) of $257.7M was insufficient to cover total dividends of $270.6M (common $245.5M + preferred $25.1M). No share repurchases occurred in the quarter. Working capital provided a net inflow of $68.8M, driven by inventory reduction ($125.0M) and increased payables/accrued liabilities ($27.6M), partially offset by a $75.8M rise in accounts receivable. Tax timing differences (deferred tax benefit of $3.0M, income tax payable decrease of $4.6M) were modest. Financing cash flow of -$443.9M was primarily driven by net commercial paper repayments of $174.1M and dividend payments, with no new debt issuance. The cash balance declined by $205.2M to $566.5M.